Your browser doesn't support javascript.
loading
Natural History of Post-Treatment Kidney Stone Fragments: A Systematic Review and Meta-Analysis.
Brain, Eleanor; Geraghty, Robert M; Lovegrove, Catherine E; Yang, Bingyuan; Somani, Bhaskar K.
Afiliación
  • Brain E; Newcastle Medical School, Newcastle-upon-Tyne, England.
  • Geraghty RM; Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, England.
  • Lovegrove CE; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, International Centre for Life, Newcastle upon Tyne, England.
  • Yang B; Department of Urology, Churchill Hospital, Oxford, England.
  • Somani BK; Nuffield Department of Surgery, Oxford University, Oxford, England.
J Urol ; 206(3): 526-538, 2021 Sep.
Article en En | MEDLINE | ID: mdl-33904756
ABSTRACT

PURPOSE:

We assessed the literature around post-treatment asymptomatic residual stone fragments and performed a meta-analysis. The main outcomes were intervention rate and disease progression. MATERIALS AND

METHODS:

We searched Ovid®, MEDLINE®, Embase™, the Cochrane Library and ClinicalTrials.gov using search terms "asymptomatic", "nephrolithiasis", "ESWL", "PCNL", "URS" and "intervention." Inclusion criteria were all studies with residual renal fragments following treatment (shock wave lithotripsy, ureteroscopy or percutaneous nephrolithotomy). Analysis was performed using 'metafor' in R and bias determined using Newcastle-Ottawa scale.

RESULTS:

From 273 articles, 18 papers (2,096 patients) had details of intervention rate for residual fragments. Aggregate intervention rates for ≤4 mm fragments rose from 19% (20 months) to 22% (50 months), while >4 mm fragments rose from 22% to 47%. Aggregate disease progression rates for ≤4 mm rose from 25% to 47% and >4 mm rose from 26% to 88%. However, there was substantial difference in definition of "disease progression." Meta-analysis comparing >4 mm against ≤4 mm fragments intervention rate for >4 mm (vs ≤4 mm) OR=1.50 (95% CI 0.70-2.30), p <0.001, I2=67.6%, tau2=0.48, Cochran's Q=11.4 (p=0.02) and Egger's regression z=3.11, p=0.002. Disease progression rate for >4 mm OR=0.06 (95% CI -0.98-1.10), p=0.91, I2=53.0%, tau2=0.57, Cochran's Q=7.11 (p=0.07) and Egger's regression z=-0.75, p=0.45. Bias analysis demonstrated a moderate risk.

CONCLUSIONS:

Larger post-treatment residual fragments are significantly more likely to require further intervention especially in the long term. Smaller fragments, although less likely to require further intervention, still carry that risk. Notably, there is no significant difference in disease progression between fragment sizes. Patients with residual fragments should be appropriately counselled and informed decision-making regarding further management should be done.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Litotricia / Cálculos Renales / Ureteroscopía / Retratamiento / Nefrolitotomía Percutánea Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Urol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Litotricia / Cálculos Renales / Ureteroscopía / Retratamiento / Nefrolitotomía Percutánea Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Urol Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
...